I'm just reading it again to me it doesn't sound as incredible as I initially thought. 66% progression free survival but currently no data on overall survival, no more safe than SOC chemotherapy and they now need to run additional phase 2 trials.
Any other thoughts?
Ann: Imugene HER-Vaxx Phase 2 PFS Data and Flags Three New Trials, page-16
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.2¢ |
Change
0.001(2.44%) |
Mkt cap ! $312.4M | |||
| Open | High | Low | Value | Volume |
| 4.1¢ | 4.3¢ | 4.1¢ | $672.3K | 16.04M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 32 | 4003556 | 4.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.2¢ | 197261 | 1 |
View Market Depth
| Last trade - 16.10pm 19/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |